| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.8M | +773.3% |
| Cost of Revenue | $1.9M | +9.1% |
| Gross Profit | -$75K | +95.1% |
| R&D Expense | $24.3M | +143.8% |
| SG&A Expense | $10.1M | +118.5% |
| Operating Income | -$38.3M | -84.7% |
| Interest Expense | $79K | -96.5% |
| Income Tax | $0 | — |
| Net Income | -$39.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $123.3M | — |
| Accounts Receivable | $87K | +2837.6% |
| Inventory | $310K | -60.0% |
| Current Assets | $125.3M | +8472.8% |
| Total Assets | $139.6M | +4877.7% |
| Current Liabilities | $6.8M | +9.1% |
| Total Liabilities | $7.9M | +15.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.5M | -34.9% |
| Capital Expenditures | $10.3M | — |
| Investing Cash Flow | -$10.3M | — |
| Financing Cash Flow | $155.1M | +1069.2% |
| Free Cash Flow | -$31.8M | -99.0% |
| -57.9% |
| EPS (Basic) | -$1.07 | +38.9% |
| EPS (Diluted) | -$1.07 | +38.9% |
| Stockholders' Equity |
| $131.7M |
| +3364.8% |